Cellectis S.A 6-K, filed Jun 28, 2024
Cellectis S.A. (CLLS)
6-K
2024-06-28
For: 2024-06-28
View Original
Added on
April 12, 2026
About this 6-K
Cellectis S.A filed this 6-K on June 28, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date of Report: June 28, 2024
Commission File Number: 001-36891
Cellectis S.A.
(Exact Name of registrant as specified in its charter)
8, rue de la Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐
Cellectis S.A.
Cellectis S.A. (the “Company”) held its Combined General Meeting of Shareholders (the “Meeting”) on June 28, 2024.
The voting results of the Meeting, which is attached as Exhibit 99.1 hereto, is incorporated by reference herein.
EXHIBITS
| Exhibit | Title | |
| 99.1 | Voting Results for the Combined General Meeting of Shareholders |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CELLECTIS S.A. | ||||||
| June 28, 2024 | By: | /s/ André Choulika | ||||
| André Choulika | ||||||
| Chief Executive Officer | ||||||
Exhibit 99.1
CELLECTIS ANNUAL SHAREHOLDERS MEETING – June 28. 2024
VOTE RESULTS
Ordinary Resolutions
| NB |
Resolution | Result | For |
Against |
Vote whithhold | Total votes | Shares represented by the votes cast |
Percentage of the share capital represented by the votes cast |
Out of voting rights |
Null voting rights |
Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 1 |
approval of the annual financial statements for the financial year ended December 31,2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1 | carried | 45 182 051 | 99.60 | % | 179 689 | 0.40 | % | 17 048 | — | 45 361 740 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 2 |
approval of the consolidated financial statements for the financial year ended December 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | carried | 45 164 516 | 99.60 | % | 180 689 | 0.40 | % | 33 583 | — | 45 345 205 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 3 |
allocation of the results for the financial year ended December 31,2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | carried | 45 178 716 | 99.60 | % | 180 489 | 0.40 | % | 19 583 | — | 45 359 205 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 4 |
allocation of losses carried forward to the “share premium” account | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | carried | 45 070 113 | 99.36 | % | 288 592 | 0.64 | % | 20 083 | — | 45 358 705 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 5 |
review of the agreements considered in articles L. 225-38 et seq. of the French Commercial Code (financing agreement with Bpifrance) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | carried | 36 404 916 | 99.45 | % | 201 042 | 0.55 | % | 20 083 | — | 36 605 958 | 34 620 529 | 34.588 | % | 8 752 747 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
1/5
CELLECTIS – ANNUAL SHAREHOLDERS MEETING – June 28, 2024
VOTE RESULTS
| NB |
Resolution | Result | For |
Against |
Vote whithhold | Total votes | Shares represented by the votes cast |
Percentage of the share capital represented by the votes cast |
Out of voting rights |
Null voting rights |
Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
review of the agreements considered in articles L. 225-38 et seq. of the French Commercial Code (subsidy and repayable advance agreement with Bpifrance) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | carried | 36 402 945 | 99.45 | % | 203 013 | 0.55 | % | 20 083 | — | 36 605 958 | 34 620 529 | 34.588 | % | 8 752 747 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 7 |
renewal of the appointment of Mr. André Choulika as a member of the board of directors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | carried | 44 631 510 | 98.39 | % | 729 346 | 1.61 | % | 17 932 | — | 45 360 856 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 8 |
renewal of the appointment of Mr. David Sourdive as a member of the board of directors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | carried | 43 090 151 | 94.99 | % | 2 270 705 | 5.01 | % | 17 932 | — | 45 360 856 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 9 |
renewal of the appointment of J.M.H. Conseil as statutory auditor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | carried | 33 583 149 | 76.76 | % | 10 169 651 | 23.24 | % | 1 625 988 | — | 43 752 800 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 10 |
appointment of KPMG as statutory auditor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | carried | 45 156 134 | 99.55 | % | 204 746 | 0.45 | % | 17 908 | — | 45 360 880 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 11 |
authorization to the Board of Directors to buy back shares of the Company | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | carried | 44 846 482 | 98.87 | % | 514 375 | 1.13 | % | 17 931 | — | 45 360 857 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 12 |
authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization for to buy back its own shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | carried | 45 052 759 | 99.33 | % | 305 495 | 0.67 | % | 20 534 | — | 45 358 254 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
2/5
CELLECTIS – ANNUAL SHAREHOLDERS MEETING – June 28, 2024
VOTE RESULTS
Extraordinary Resolutions
| N° |
Résolution | Résultat | Pour |
Contre |
Abstention | Total des voix prises en compte |
Actions représentées par les voix exprimées |
Proportion du capital social représenté par les voix exprimées |
Voix exclues | Voix nulles | Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 |
up-date of Article 24 of the articles of association “Loss of one half of share capital” in order to comply with legal provisions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | carried | 45 151 875 | 99.55 | % | 206 370 | 0.45 | % | 20 543 | — | 45 358 245 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 14 |
|
delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities. with cancellation of shareholders’ preferential subscription rights in favor of the European Investment Bank or of other entities that may succeed EIB. according to any finance agreement entered or be entered |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | carried | 43 926 971 | 96.87 | % | 1 418 183 | 3.13 | % | 33 634 | — | 45 345 154 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 15 |
|
delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with experience in the health or biotech sector) |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | carried | 44 978 073 | 99.16 | % | 381 081 | 0.84 | % | 19 634 | — | 45 359 154 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 16 |
|
delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities. with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (credit institutions. investment services providers or members of an investment pool guaranteeing the completion of the considered issue) |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | carried | 44 971 324 | 99.14 | % | 388 551 | 0.86 | % | 18 913 | — | 45 359 875 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 17 |
|
delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any other securities, with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics (industrial companies. institutions or entities active in the health or biotechnology sector) |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | carried | 44 957 300 | 99.14 | % | 388 511 | 0.86 | % | 32 977 | — | 45 345 811 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
3/5
CELLECTIS – ANNUAL SHAREHOLDERS MEETING – June 28, 2024
VOTE RESULTS
| N° |
Résolution | Résultat | Pour |
Contre |
Abstention | Total des voix prises en compte |
Actions représentées par les voix exprimées |
Proportion du capital social représenté par les voix exprimées |
Voix exclues | Voix nulles | Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 |
|
delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders’ preferential subscription rights in favor of a category of persons meeting specified characteristics the framework of an equity or bond financing agreement |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | carried | 44 971 364 | 99.14 | % | 388 511 | 0.86 | % | 18 913 | — | 45 359 875 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 19 |
|
delegation of authority to be granted to the Board of Directors to decide on the issuance of ordinary shares to be issued immediately or in the future by the Company. with cancellation of the shareholders’ preferential subscription rights, to the benefit of a category of persons meeting specified characteristics within the framework of an equity financing program on the American market known as “At-the-market” or “ATM” |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | carried | 44 957 603 | 99.14 | % | 388 511 | 0.86 | % | 32 674 | — | 45 346 114 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 20 |
|
delegation of authority to be granted to the Board of Directors to immediately or in the future increase the share capital by issuing ordinary shares or any other securities giving access to the share capital. with the shareholders’ preferential subscription rights maintained |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | carried | 45 029 850 | 99.28 | % | 328 304 | 0.72 | % | 20 634 | — | 45 358 154 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 21 |
|
delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of the shareholders’ pre-emptive subscription rights by way of a public offering (other than the offers referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code) |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | carried | 44 971 727 | 99.15 | % | 387 411 | 0.85 | % | 19 650 | — | 45 359 138 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 22 |
|
delegation of authority to be granted to the Board of Directors to increase the capital immediately or in the future through the issue of ordinary shares or any securities, with cancellation of’ pre-emptive subscription rights by way of an offering referred to in paragraph 1° of Article L. 411-2 of the French Monetary and Financial Code |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | carried | 44 957 703 | 99.11 | % | 401 451 | 0.89 | % | 19 634 | — | 45 359 154 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 23 |
|
delegation of authority to be granted to the Board of Directors to increase the amount of each of the issues with or without pre-emptive subscription rights which will be decided pursuant to the above delegations |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | carried | 44 981 679 | 99.17 | % | 377 478 | 0.83 | % | 19 631 | — | 45 359 157 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
4/5
CELLECTIS – ANNUAL SHAREHOLDERS MEETING – June 28, 2024
VOTE RESULTS
| N° |
Résolution | Résultat | Pour |
Contre |
Abstention | Total des voix prises en compte |
Actions représentées par les voix exprimées |
Proportion du capital social représenté par les voix exprimées |
Voix exclues | Voix nulles | Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 |
|
determination of the total amount of the capital increases that may be carried out under the aforementioned delegations (excluding the share capital increase with upholding of the shareholders’ preferential subscription rights and the share capital increase in favor of the European Investment Bank or of other entities that may succeed EIB. according to any finance agreement) |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | carried | 45 149 182 | 99.54 | % | 209 972 | 0.46 | % | 19 634 | — | 45 359 154 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 25 |
delegation of authority to be granted to the board of directors to increase the capital by incorporation of premiums. reserves. profits or other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | carried | 45 115 130 | 99.46 | % | 244 026 | 0.54 | % | 19 632 | — | 45 359 156 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 26 |
|
authorization to be granted to the Board of Directors to grant options to subscribe for or purchase ordinary shares in the Company, entailing a waiver by the shareholders of their preferential subscription rights |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | carried | 35 196 342 | 96.19 | % | 1 395 967 | 3.81 | % | 8 786 479 | — | 36 592 309 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 27 |
|
authorization to be granted to the Board of Directors to proceed with free allocations of ordinary shares of the Company, to the benefit of employees and/or corporate officers of the Company and its subsidiaries, entailing the waiver by the shareholders of their preferential subscription rights |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | carried | 35 243 114 | 96.28 | % | 1 363 293 | 3.72 | % | 8 772 381 | — | 36 606 407 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 28 |
|
determination of the total amount of the capital increases that may be carried out by virtue of the aforementioned authorization to grant options to subscribe for or purchase shares and the aforementioned authorization to grant free shares |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | carried | 45 137 900 | 99.51 | % | 221 154 | 0.49 | % | 19 734 | — | 45 359 054 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
| 29 |
|
delegation of authority to be granted to the Board of Directors for the purpose of carrying out a capital increase whose subscription will be reserved for members of a company savings plan established pursuant to Articles L. 3332-1 et seq. of the Labor Code |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | rejected | 9 064 329 | 19.99 | % | 36 287 053 | 80.01 | % | 27 406 | — | 45 351 382 | 40 493 776 | 40.455 | % | 0 | 0 | 40.455 | % | |||||||||||||||||||||||||||||||||||||||
5/5